Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy.
about
HIV infection and osteoporosisBiological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaquesHIV infection and bone disease.Elevated suppressor of cytokine signaling-1 (SOCS-1): a mechanism for dysregulated osteoclastogenesis in HIV transgenic ratsLow bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected womenLow bone-mineral density in patients with HIV: pathogenesis and clinical significance.The effect of HIV-hepatitis C co-infection on bone mineral density and fracture: a meta-analysis.Aging, human immunodeficiency virus, and bone health.Bone disease in HIV infection: a practical review and recommendations for HIV care providers.Symptomatic hyperlactatemia in an HIV-positive patient: a case report and discussion.Effects of HIV infection and antiretroviral therapy with ritonavir on induction of osteoclast-like cells in postmenopausal womenHuman immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular diseasePathogenesis of osteopenia/osteoporosis induced by highly active anti-retroviral therapy for AIDS.Beneficial effects of physical activity in an HIV-infected woman with lipodystrophy: a case report.Longitudinal analysis of bone density in human immunodeficiency virus-infected womenCharacteristics of foot fractures in HIV-infected patients previously treated with tenofovir versus non-tenofovir-containing highly active antiretroviral therapy.Bone disease in HIV infection.Osteopenia and osteoporosis in people living with HIV: multiprofessional approachHigher rates of bone loss in postmenopausal HIV-infected women: a longitudinal study.Adverse effects of antiretroviral therapy: focus on bone density.Bone mineral density in human immunodeficiency virus-1 infected men with hypogonadism prior to highly-active-antiretroviral-therapy (HAART).Bone disorders associated with the human immunodeficiency virus: pathogenesis and management.Effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: a randomized, controlled study.Impact of age on markers of HIV-1 diseaseMore than osteoporosis: age-specific issues in bone health.Prevalence and risk factors of low bone mineral density in Korean HIV-infected patients: impact of abacavir and zidovudineFracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system.Low bone mineral density and associated risk factors in HIV-infected patients.Is PPARγ a prospective player in HIV-1-associated bone disease?Hormonal contraception and HIV-positive women: metabolic concerns and management strategiesBone mineral density in HIV participants randomized to raltegravir and lopinavir/ritonavir compared with standard second line therapy.HIV and Bone Disease: A Perspective of the Role of microRNAs in Bone Biology upon HIV InfectionContinuous antiretroviral therapy decreases bone mineral density.High prevalence of low bone mass and associated factors in Korean HIV-positive male patients undergoing antiretroviral therapy.Evolution and predictors of change in total bone mineral density over time in HIV-infected men and women in the nutrition for healthy living studyWeight and lean body mass change with antiretroviral initiation and impact on bone mineral density.Therapeutic options for low bone mineral density in HIV-infected subjects.Osteoporosis and bone health in HIV.Sciadopitysin alleviates methylglyoxal-mediated glycation in osteoblastic MC3T3-E1 cells by enhancing glyoxalase system and mitochondrial biogenesis.Alveolar bone in human immunodeficiency virus infection: is it changed by long-term antiretroviral therapy?
P2860
Q26853139-0613171D-0515-4FE0-BE80-0F017D47D25FQ28775900-E7426D29-ECEB-4CC8-9776-A0F193B37072Q30249771-A374164B-695F-4E10-90CF-16C400317C4CQ33723186-9D00B7B5-586F-456F-A9C8-F7A314A1D049Q33736156-B545BED2-AC6B-4322-AB3F-AEAC676CB399Q33844059-50E02645-ACEF-4C9B-819C-13BB5F803B20Q33916243-117B0F74-D03F-4E22-BB0F-695D744CB971Q34160511-EE6C736E-67DE-4A99-A375-03B2A96D3420Q35019051-A79641C8-3C35-4C58-A93A-F6B34F28AF3EQ35049863-D2A99AFA-BC19-45D3-9626-4E3F1A8CF1ACQ35055196-ADA77DD0-27A3-404F-ADB1-9C4DCC4933AAQ35104006-9E0740BA-29C8-4D3F-B665-7504375C63B2Q35126803-B6D3625C-D900-4F02-91BB-E7BEEC0968CBQ35252444-7FE8BC75-56D1-4803-B312-DDE1460F012DQ35513234-EE6652C3-B7B4-4089-9159-458BAE842EA3Q35557338-61301467-8E16-443F-A84F-4F2FD4E1407CQ35593296-408433CD-4BB8-4BEB-B36C-6046C337A59DQ35671760-837ADC4B-3F5D-4F84-97C7-7C45A1964F24Q35744467-47E1A613-CE5A-4292-9F92-892F305C3E01Q35779323-264F9600-8DF3-4234-9A0C-13CF32A3FAC2Q35959017-D5532D5A-A128-401F-9C7B-866303D83279Q35998003-B63259A6-8757-4E34-8EF5-CFE3E13CF5DDQ36726178-70D6CAB3-D95A-477A-8344-D69034109A49Q36763762-3861B1F5-8989-4152-9413-30B25C7E59BBQ36877351-BF3A548C-658B-4E3A-A986-1965FF14FDDBQ36917137-34DDAA6A-C335-4D89-8286-0E6C1F36E04EQ36938343-5C0103CC-5AF8-439A-93D2-9C2AA13B98D7Q37115224-72A1970C-A54B-4E26-8782-CC95D6032A26Q37137545-5D181DD1-36FD-4CEF-97D3-26851C48A3E8Q37202281-4C16772E-52FE-4ADC-B576-F8B288DBBD7EQ37272765-25DA2A0B-A591-4C5E-9624-3364C90E7D09Q37304461-BF107E3E-0A60-4200-96EE-1272D7E593A3Q37357149-CBD2B03C-403F-4FC9-9F2B-352A2D8456B5Q37466644-32D3FDF2-087B-4FC0-B38B-9E0F7B274E6FQ37596221-0D135EF6-6E0F-49BC-BB94-C22B80321BCBQ37665151-BBCE5A90-3F47-4ECC-8EEA-1E1775D40C19Q38005045-A0E08171-509E-4A5D-B2C2-461AEAEE24A9Q38009732-CD81695F-451A-477A-B066-40CE3E936EB8Q39015617-AAC21C4A-FC58-45FD-9767-A6FFE64B3999Q39172721-7B6ABC4E-A8FA-4CD3-B130-D4951C894823
P2860
Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Osteopenia in HIV-infected men ...... ht pre-antiretroviral therapy.
@en
Osteopenia in HIV-infected men ...... ht pre-antiretroviral therapy.
@nl
type
label
Osteopenia in HIV-infected men ...... ht pre-antiretroviral therapy.
@en
Osteopenia in HIV-infected men ...... ht pre-antiretroviral therapy.
@nl
prefLabel
Osteopenia in HIV-infected men ...... ht pre-antiretroviral therapy.
@en
Osteopenia in HIV-infected men ...... ht pre-antiretroviral therapy.
@nl
P2093
P1433
P1476
Osteopenia in HIV-infected men ...... ht pre-antiretroviral therapy.
@en
P2093
P304
P356
10.1097/00002030-200104130-00005
P407
P577
2001-04-01T00:00:00Z